Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taku Okazaki

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
The Journal of Rheumatology|November 3, 2005
Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjögren's syndromeMasaya Kobayashi, Seiji Kawano, Saori Hatachi, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptorsDavid Yin-Wei Lin, Yoshimasa Tanaka, Masashi Iwasaki, et al.
The Journal of Experimental Medicine|February 9, 2011
PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in miceTaku Okazaki, Il-mi Okazaki, Jian Wang, et al.
Immunity|April 12, 2022
Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunityTakumi Maruhashi, Daisuke Sugiura, Il-Mi Okazaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2012
Intestinal CX3C chemokine receptor 1(high) (CX3CR1(high)) myeloid cells prevent T-cell-dependent colitisHisako Kayama, Yoshiyasu Ueda, Yukihisa Sawa, et al.
Journal of Autoimmunity|September 22, 2017
Paradoxical development of polymyositis-like autoimmunity through augmented expression of autoimmune regulator (AIRE)Hitoshi Nishijima, Tatsuya Kajimoto, Yoshiki Matsuoka, et al.
Cancer Science|February 27, 2016
Report on the use of non-clinical studies in the regulatory evaluation of oncology drugsYoshihiro Hayakawa, Manabu Kawada, Hiroyoshi Nishikawa, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
The Journal of Rheumatology|November 3, 2005
Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjögren's syndromeMasaya Kobayashi, Seiji Kawano, Saori Hatachi, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptorsDavid Yin-Wei Lin, Yoshimasa Tanaka, Masashi Iwasaki, et al.
The Journal of Experimental Medicine|February 9, 2011
PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in miceTaku Okazaki, Il-mi Okazaki, Jian Wang, et al.
Immunity|April 12, 2022
Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunityTakumi Maruhashi, Daisuke Sugiura, Il-Mi Okazaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2012
Intestinal CX3C chemokine receptor 1(high) (CX3CR1(high)) myeloid cells prevent T-cell-dependent colitisHisako Kayama, Yoshiyasu Ueda, Yukihisa Sawa, et al.
Journal of Autoimmunity|September 22, 2017
Paradoxical development of polymyositis-like autoimmunity through augmented expression of autoimmune regulator (AIRE)Hitoshi Nishijima, Tatsuya Kajimoto, Yoshiki Matsuoka, et al.
Cancer Science|February 27, 2016
Report on the use of non-clinical studies in the regulatory evaluation of oncology drugsYoshihiro Hayakawa, Manabu Kawada, Hiroyoshi Nishikawa, et al.
Pageof 6